Medvedev A E, Veselovsky A V, Shvedov V I, Tikhonova O V, Moskvitina T A, Fedotova O A, Axenova L N, Kamyshanskaya N S, Kirkel A Z, Ivanov A S
Laboratory of Biochemistry, Russian Academy of Medical Sciences, Moscow, Russia.
J Chem Inf Comput Sci. 1998 Nov-Dec;38(6):1137-44. doi: 10.1021/ci9802068.
A series of pyrazinocarbazoles, analogues of short acting antidepressant pirlindole (2,3,3a,4,5,6-hexahydro-8-methyl-1H-pyrazino[3,2,1-j,k]carbazole hydrochloride), were tested as inhibitors of monoamine oxidase A (MAO-A) and B (MAO-B). Rigid analogues exhibited potent and selective inhibition of MAO-A and have size limits (X:Y:Z) of 13.0 x 7.0 x 4.4 A. Besides MAO-A inhibition flexible analogues also demonstrated potent inhibition of MAO-B and in contrast to rigid analogues their inhibitory activity did not show the dependence on these sizes. The qualitative information (steric and electrostatic coefficients) from the 3D-QSAR with CoMFA models for MAO-A and -B are different, and this information can be used to determine the structural features influencing inhibitor selectivity.
一系列吡嗪咔唑类化合物,即短效抗抑郁药匹克隆朵(2,3,3a,4,5,6-六氢-8-甲基-1H-吡嗪并[3,2,1-j,k]咔唑盐酸盐)的类似物,被作为单胺氧化酶A(MAO-A)和B(MAO-B)的抑制剂进行了测试。刚性类似物对MAO-A表现出强效且选择性的抑制作用,其尺寸限制(X:Y:Z)为13.0×7.0×4.4埃。除了抑制MAO-A外,柔性类似物还对MAO-B表现出强效抑制作用,与刚性类似物不同的是,它们对MAO-B抑制活性不依赖于这些尺寸。来自MAO-A和-B的CoMFA模型的3D-QSAR的定性信息(空间和静电系数)不同,并且该信息可用于确定影响抑制剂选择性的结构特征。